# Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy

> **NCT04454580** · — · UNKNOWN · sponsor: **Ospedale Maggiore Di Trieste** · enrollment: 15 (estimated)

## Conditions studied

- Acute Myeloid Leukemia, Adult
- Hypomethylating Agents
- Venetoclax

## Interventions

- **DRUG:** Venetoclax

## Key facts

- **NCT ID:** NCT04454580
- **Lead sponsor:** Ospedale Maggiore Di Trieste
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-01
- **Primary completion:** 2020-09-16
- **Final completion:** 2020-09-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04454580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04454580, "Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04454580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*